Dr. Reddy's Laboratories
RDY
#1699
Rank
โ‚ฌ10.19 B
Marketcap
12,19ย โ‚ฌ
Share price
0.35%
Change (1 day)
-10.28%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ0.56 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total debt is โ‚ฌ0.56 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dr. Reddy's Laboratories - Total debt on balance sheet (from 2001 to 2025)

Total debt by year

Year Total debt Change
2025-03-31โ‚ฌ0.50 B127.3%
2024-03-31โ‚ฌ0.22 B47.4%
2023-03-31โ‚ฌ0.15 B-62.51%
2022-03-31โ‚ฌ0.40 B14.07%
2021-03-31โ‚ฌ0.35 B32.65%
2020-03-31โ‚ฌ0.26 B-45.97%
2019-03-31โ‚ฌ0.49 B-22.14%
2018-03-31โ‚ฌ0.63 B-10.78%
2017-03-31โ‚ฌ0.70 B59.49%
2016-03-31โ‚ฌ0.44 B-31.03%
2015-03-31โ‚ฌ0.64 B19.05%
2014-03-31โ‚ฌ0.54 B2.38%
2013-03-31โ‚ฌ0.52 B11.37%
2012-03-31โ‚ฌ0.47 B26.79%
2011-03-31โ‚ฌ0.37 B53.91%
2010-03-31โ‚ฌ0.24 B-17.34%
2009-03-31โ‚ฌ0.29 B-3.7%
2008-03-31โ‚ฌ0.30 B-29.05%
2007-03-31โ‚ฌ0.43 B-25.53%
2006-03-31โ‚ฌ0.57 B1048.66%
2005-03-31โ‚ฌ50.36 M434.4%
2004-03-31โ‚ฌ9.42 M47%
2003-03-31โ‚ฌ6.41 M78.97%
2002-03-31โ‚ฌ3.58 M-96.28%
2001-03-31โ‚ฌ96.38 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
โ‚ฌ52.26 B 9,134.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.66 B 2,491.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 3,521.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
โ‚ฌ27.50 B 4,759.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ21.92 B 3,774.71%๐Ÿ‡ซ๐Ÿ‡ท France